Web Nerds

About maf2014

This author has not yet filled in any details.
So far maf2014 has created 381 entries.


Proven Leader to Accelerate Data-Driven and Digital Marketing Solutions that Connect Businesses with Consumers

LIVONIA, Mich., Oct. 14, 2019: Valassis, the leader in marketing technology and consumer engagement, today announced the promotion of Cali Tran to president and CEO. Tran will lead Valassis’ growth strategy and go-to-market execution

October 14th, 2019|Press Center|

AM General and Fiat Chrysler Automobiles Partner to Develop New Light Tactical Concept Vehicle – Jeep Gladiator XMT

WASHINGTON, D.C., October 14, 2019 – Leading manufacturer of light tactical vehicles, AM General, together with the Jeep Brand of Fiat Chrysler Automobiles (FCA), today introduced a new light tactical concept vehicle at the Annual Meeting and Exposition of the Association of the U.S.

October 14th, 2019|Press Center|

Scientific Games and Nederlandse Loterij Expand Partnership with Complete Digital Sports Betting Solution

LAS VEGAS, Oct. 10, 2019 /PRNewswire/ — Scientific Games Corporation (NASDAQ: SGMS) (“Scientific Games” or the “Company”) and Nederlandse Loterij expanded their partnership to bring the Dutch Lottery’s players a full digital sports betting solution.

The expanded sports partnership will advance sports offering with the launch of OpenSports, the Company’s

October 10th, 2019|Press Center|

Scientific Games Launches OpenGaming™, an End-to-End Digital Ecosystem

LAS VEGAS, Oct. 9, 2019 /PRNewswire/ — Scientific Games Corporation (NASDAQ: SGMS) (“Scientific Games” or “SG”) has unveiled OpenGaming, the end-to-end digital ecosystem for operators looking to provide a new wave of immersive gaming experiences for their players through one seamless integration.

The OpenGaming ecosystem is home to trusted content aggregation technology, a

October 9th, 2019|Press Center|

Scientific Games Reimagines Play at G2E 2019

Industry leader brings exciting new games, revolutionary technology and player-centric solutions to show floor.

October 9th, 2019|Press Center|

RetailMeNot’s Exclusive Wedding Cost Breakdown With a Lifestyle and Etiquette Expert

AUSTIN, Texas, Oct. 9, 2019 /PRNewswire/ — Attending a wedding can be an expensive ordeal for all involved. Whether a guest, member of a bridal party, or getting married yourself – there is a lot of speculation about etiquette and what you are expected to spend.

October 9th, 2019|Press Center|

AM General Focuses On Current Readiness and Future Technologies at AUSA 2019

The Humvee Hawkeye Mobile Howitzer, outfitted with the company’s patented soft recoil technology, highlights the company’s responsiveness to the U.S. Army’s requirements and ability to keep pace with the changing security environment.
SOUTH BEND, Ind., October 09, 2019 – Global mobility solutions provider AM General will

October 9th, 2019|Press Center|

Solaire Resort & Casino is the First to Install Scientific Games’ Dualos™X Slot Cabinets in Asia

Las Vegas and Macau – October 7, 2019 – Scientific Games Corporation (NASDAQ:SGMS) (“Scientific Games” or the “Company”) announced today that Solaire Resort & Casino is the first integrated resort in Asia to place an order for DualosX gaming cabinets. DualosX is the latest

October 7th, 2019|Press Center|

vTv to Host Key Opinion Leader Event to Discuss the Type 1 Diabetes Treatment Landscape and Emerging Therapies as Adjuncts to Insulin

HIGH POINT, N.C. , Oct. 03, 2019 (GLOBE NEWSWIRE) — vTv Therapeutics Inc. (Nasdaq: VTVT), today announced that the Company will host a key opinion leader (KOL) presentation and webcast discussing the type 1 diabetes (T1D) treatment landscape and emerging therapies in New York City on Tuesday, October 8, 2019 from 8:30 am to 10:00

October 3rd, 2019|Press Center|

SIGA Completes Clinical Studies for IV Formulation of TPOXX®, NDA to be Submitted in 2020

October 3, 2019 at 7:30 AM EDT

PDF Version

NEW YORK, Oct. 03, 2019 (GLOBE NEWSWIRE) — SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that it has reached concurrence with the US Food and Drug Administration (FDA) that no further clinical studies

October 3rd, 2019|Press Center|